Blood formula may predict survival after major surgery bleeding
NCT ID NCT06021184
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study observes 1,679 surgical patients who had major bleeding and received blood transfusions. Researchers want to see if giving more fibrinogen (a protein that helps blood clot) early on improves survival and daily function after 30 days. The goal is to find the best balance of blood products to use during emergencies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MASSIVE TRANSFUSION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ankara Bilkent city hospital
Ankara, Çankaya, 06800, Turkey (Türkiye)